Olive oil in the prevention and management of type 2 diabetes mellitus: A systematic review and meta-analysis of cohort studies and intervention trials

Nutrition and Diabetes

Volumn 7, Issue 4, 2017, Pages

  Schwingshackl, L ^a   Lampousi, A M ^a   Portillo, M P ^b,c   Romaguera, D ^c,d   Hoffmann, G ^e   Boeing, H ^a  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^c Instituto de Salud Carlos III   (Spain)

^d HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^e UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; OLIVE OIL;

ARTICLE; COHORT ANALYSIS; DIET SUPPLEMENTATION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HUMAN; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; RISK REDUCTION; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; BLOOD; CHEMISTRY; DIET THERAPY; METABOLISM; OLIVE TREE;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HUMANS; OLEA; OLIVE OIL;

EID: 85017365200     PISSN: None     EISSN: 20444052     Source Type: Journal    
DOI: 10.1038/nutd.2017.12     Document Type: Article

References (47)

1. WHO. Fact Sheet No 312: Diabetes. WHO: Geneva, 2013.
2. International Diabetes Federation, 6th edn. 2013. https://www. idf. org/sites/default/files/EN-6E-Atlas-Full-0. pdf (accessed 19 February 2016).
3. Schwingshackl L, Missbach B, Konig J, Hoffmann G. Adherence to a Mediterranean diet and risk of diabetes: A systematic review and meta-analysis. Public Health Nutr 2015; 18: 1292-1299.
4. Huo R, Du T, Xu Y, Xu W, Chen X, Sun K, et al. Effects of Mediterranean-style diet on glycemic control, weight loss and cardiovascular risk factors among type 2 diabetes individuals: A meta-analysis. Eur J Clin Nutr 2015; 69: 1200-1208.
5. Trichopoulou A, Martinez-Gonzalez MA, Tong TY, Forouhi NG, Khandelwal S, Prabhakaran D, et al. Definitions and potential health benefits of the Mediterranean diet: Views from experts around the world. BMC Med 2014; 12: 112.
6. Schwingshackl L, Hoffmann G. Does a Mediterranean-type diet reduce cancer risk? Curr Nutr Rep 2016; 5: 9-17.
7. Lopez-Miranda J, Perez-Jimenez F, Ros E, De Caterina R, Badimon L, Covas MI, et al. Olive oil and health: Summary of the II International Conference on Olive Oil and Health Consensus Report, Jaen and Cordoba (Spain) 2008. Nutr Metab Cardiovasc Dis 2010; 20: 284-294.
8. Qian F, Korat AA, Malik V, Hu FB. Metabolic effects of monounsaturated fatty acid-enriched diets compared with carbohydrate or polyunsaturated fatty acid-enriched diets in patients with type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials. Diabetes Care 2016; 39: 1448-1457.
9. Schwingshackl L, Hoffmann G. Monounsaturated fatty acids and risk of cardiovascular disease: Synopsis of the evidence available from systematic reviews and meta-analyses. Nutrients 2012; 4: 1989-2007.
10. Schwingshackl L, Strasser B, Hoffmann G. Effects of monounsaturated fatty acids on glycaemic control in patients with abnormal glucose metabolism: A systematic review and meta-analysis. Ann Nutr Metab 2011; 58: 290-296.
11. Schwingshackl L, Strasser B. High-MUFA diets reduce fasting glucose in patients with type 2 diabetes. Ann Nutr Metab 2012; 60: 33-34.
12. Schwingshackl L, Strasser B, Hoffmann G. Effects of monounsaturated fatty acids on cardiovascular risk factors: A systematic review and meta-analysis. Ann Nutr Metab 2011; 59: 176-186.
13. Schwingshackl L, Hoffmann G. Monounsaturated fatty acids, olive oil and health status: A systematic review and meta-analysis of cohort studies. Lipids Health Dis 2014; 13: 154.
14. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283: 2008-2012.
15. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. Ann Intern Med 2009; 151: W65-W94.
16. American Diabetes Association. (2) Classification and diagnosis of diabetes. Diabetes Care 2015; 38: S8-S16.
17. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011; 343: D5928.
18. Schwingshackl L, Knüppel S, Schwedhelm C, Hoffmann G, Missbach B, Stelmach-Mardas M, et al. Perspective: NutriGrade: A scoring system to assess and judge the meta-evidence of randomized controlled trials and cohort studies in nutrition research. Adv Nutr 2016; 7: 994-1004.
19. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992; 135: 1301-1309.
20. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose-response data. Stata J 2006; 6: 40-57.
21. Durrleman S, Simon R. Flexible regression models with cubic splines. Stat Med 1989; 8: 551-561.
22. Higgins JPT, Green S (eds). Cochrane Handbook for Systematic Reviews of Interventions Version 510 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www. cochrane-handbook. org. 0-674.
23. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-560.
24. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002; 21: 1539-1558.
25. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
26. Patel PS, Cooper AJM, O'Connell TC, Kuhnle GGC, Kneale CK, Mulligan AM, et al. Serum carbon and nitrogen stable isotopes as potential biomarkers of dietary intake and their relation with incident type 2 diabetes: The EPIC-Norfolk study. Am J Clin Nutr 2014; 100: 708-718.
27. Di Angelantonio E, Gao P, Khan H, Butterworth AS, Wormser D, Kaptoge S, et al. Glycated hemoglobin measurement and prediction of cardiovascular disease. JAMA 2014; 311: 1225-1233.
28. Hoffman R, Gerber M. Can rapeseed oil replace olive oil as part of a Mediterranean-style diet? Br J Nutr 2014; 112: 1882-1895.
29. Gladine C, Meunier N, Blot A, Bruchet L, Pages X, Gaud M, et al. Preservation of micronutrients during rapeseed oil refining: A tool to optimize the health value of edible vegetable oils? Rationale and design of the Optim'Oils randomized clinical trial. Contemp Clin Trials 2011; 32: 233-239.
30. Vermunt SH, Beaufrere B, Riemersma RA, Sebedio JL, Chardigny JM, Mensink RP. Dietary trans alpha-linolenic acid from deodorised rapeseed oil and plasma lipids and lipoproteins in healthy men: The TransLinE Study. Br J Nutr 2001; 85: 387-392.
31. Frankel E. Lipid Oxidation, 2nd edn. Press BO: Oxford, Cambridge, Philadelphia, New Delhi, 2005.
32. Forouhi NG, Imamura F, Sharp SJ, Koulman A, Schulze MB, Zheng J, et al. Association of plasma phospholipid n-3 and n-6 polyunsaturated fatty acids with type 2 diabetes: The EPIC-InterAct Case-Cohort Study. PLoS Med 2016; 13: E1002094.
33. Imamura F, Micha R, Wu JH, de Oliveira Otto MC, Otite FO, Abioye AI, et al. Effects of saturated fat, polyunsaturated fat, monounsaturated fat, and carbohydrate on glucose-insulin homeostasis: A systematic review and meta-analysis of randomised controlled feeding trials. PLoS Med 2016; 13: E1002087.
34. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am J Clin Nutr 2003; 77: 1146-1155.
35. Ramsden CE, Zamora D, Majchrzak-Hong S, Faurot KR, Broste SK, Frantz RP, et al. Re-evaluation of the traditional diet-heart hypothesis: Analysis of recovered data from Minnesota Coronary Experiment (1968-73). BMJ 2016; 353: I1246.
36. Servili M, Sordini B, Esposto S, Urbani S, Veneziani G, Di Maio I, et al. Biological activities of phenolic compounds of extra virgin olive oil. Antioxidants 2013; 3: 1-23.
37. Hanhineva K, Törrönen R, Bondia-Pons I, Pekkinen J, Kolehmainen M, Mykkänen H, et al. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 2010; 11: 1365-1402.
38. Xiao JB, Högger P. Dietary polyphenols and type 2 diabetes: Current insights and future perspectives. Curr Med Chem 2015; 22: 23-38.
39. Medina-Remón A, Tresserra-Rimbau A, Pons A, Tur JA, Martorell M, Ros E, et al. Effects of total dietary polyphenols on plasma nitric oxide and blood pressure in a high cardiovascular risk cohort. The PREDIMED randomized trial. Nutr Metab Cardiovasc Dis 2015; 25: 60-67.
40. de Bock M, Derraik JG, Brennan CM, Biggs JB, Morgan PE, Hodgkinson SC, et al. Olive (Olea europaea L. ) leaf polyphenols improve insulin sensitivity in middleaged overweight men: A randomized, placebo-controlled, crossover trial. PLoS One 2013; 8: E57622.
41. Wainstein J, Ganz T, Boaz M, Bar Dayan Y, Dolev E, Kerem Z, et al. Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats. J Med Food 2012; 15: 605-610.
42. Tierney AC, Roche HM. The potential role of olive oil-derived MUFA in insulin sensitivity. Mol Nutr Food Res 2007; 51: 1235-1248.
43. Schwingshackl L, Hoffmann G. Long-term effects of low glycemic index/load vs. high glycemic index/load diets on parameters of obesity and obesity-associated risks: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis 2013; 23: 699-706.
44. Owen RW, Mier W, Giacosa A, Hull WE, Spiegelhalder B, Bartsch H. Phenolic compounds and squalene in olive oils: The concentration and antioxidant potential of total phenols, simple phenols, secoiridoids, lignansand squalene. Food Chem Toxicol 2000; 38: 647-659.
45. Aguiar PM, Brito Gde C, Lima Tde M, Santos AP, Lyra Jr DP, Storpirtis S. Investigating sources of heterogeneity in randomized controlled trials of the effects of pharmacist interventions on glycemic control in type 2 diabetic patients: A systematic review and meta-analysis. PLoS One 2016; 11: E0150999.
46. Gorst C, Kwok CS, Aslam S, Buchan I, Kontopantelis E, Myint PK, et al. Long-term glycemic variability and risk of adverse outcomes: A systematic review and meta-analysis. Diabetes Care 2015; 38: 2354-2369.
47. Tay J, Thompson CH, Brinkworth GD. Glycemic variability: Assessing glycemia differently and the implications for dietary management of diabetes. Annu Rev Nutr 2015; 35: 389-424.